Dongwha wins USA patent for its antibiotic of multidrug-resistant bacteria

Published: 2004-08-27 06:56:00

Updated: 2004-08-27 06:56:00

Dongwha Pharm said that it recently won from the United States a patent relating to photoactive 7-pyrrolidine quinoline carboxyl acid derivative and its manufacturing method for the treatment of methicillin-resistant or quinoline-resistant bacteria.

The photoactive naphtylidine derivative is also effective in the treatment of tuberculosis, including intractable infectious diseases and is now...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.